Spago Nanomedical AB (publ)

OM:SPAGO Stock Report

Market Cap: SEK 93.3m

Spago Nanomedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SPAGO?
Owner TypeNumber of SharesOwnership Percentage
Institutions19,898,6465.71%
Individual Insiders140,115,65240.2%
General Public188,181,90854%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 54.9%.

Top Shareholders

Top 19 shareholders own 45.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.2%
Peter Lindell
91,098,400SEK 24.4m0%no data
5.49%
Mikael Lönn
19,104,150SEK 5.1m0%no data
3.54%
Avanza Fonder AB
12,325,486SEK 3.3m0%no data
3.27%
Eva Redhe
11,399,853SEK 3.1m0%no data
2.45%
Tiel Ridderstad
8,519,155SEK 2.3m0%no data
1.53%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
5,334,199SEK 1.4m0%0.02%
0.89%
Filippa Lindström
3,096,494SEK 829.9k0%no data
0.75%
Håkan Ekvall
2,594,724SEK 695.4k0%no data
0.64%
Futur Pension Försäkringsaktiebolag, Asset Management Arm
2,230,223SEK 597.7k0%0.02%
0.59%
Thord Wilkne
2,044,214SEK 547.9k0%no data
0.23%
Alan Raffensperger
808,667SEK 216.7k0%no data
0.14%
Hans Arwidsson
497,000SEK 133.2k0%no data
0.11%
Mats Hansen
385,252SEK 103.2k0%no data
0.057%
Kari Gronas
199,999SEK 53.6k0%no data
0.048%
Oskar Axelsson
167,812SEK 45.0k0%no data
0.021%
Nicklas Westerholm
72,432SEK 19.4k0%no data
0.019%
Hanna Olsson
67,500SEK 18.1k0%no data
0.017%
Paul Hargreaves
60,000SEK 16.1k0%no data
0.0025%
FCG Fonder AB
8,738SEK 2.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 18:59
End of Day Share Price 2025/02/07 00:00
Earnings2024/12/30
Annual Earnings2024/12/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Spago Nanomedical AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Klas PalinPenser Access
Johan UnnerusRedeye